What type of study is this?

This is a RCT study (also classified as: Human Clinical Trial).

August 17, 2025CureusOpen Access

Comparative Effectiveness of Pitavastatin Versus Atorvastatin on Lipid Profile and Blood Sugar in Patients of Diabetic Dyslipidemia: An Open-Label Comparative Study

View Full Paper

Ask AI

Bookmark

Pitavastatin significantly increased HDL levels and improved blood glucose compared to atorvastatin.
Patients taking pitavastatin showed a notable reduction in fasting blood glucose levels with a p-value of 0.004.
This randomized study involved 84 diabetic patients with an average age of 55–70 years over 12 weeks.
Pitavastatin was more cost-effective in controlling blood glucose and lipid levels compared to atorvastatin.

No takes yet. Share an insight, caveat, or question.

Open-label study shows pitavastatin improves lipid profile and blood glucose in diabetic dyslipidemia, suggesting cost-effectiveness.

Devi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark